Evidence map›Paper›PMID 34728267›Full record

ArticleThe Journal of infection2022

Prevalence of SARS-CoV-2 antibodies after one-year follow up among workers in a research institute in Japan.

Akihiko Nishikimi, Ken Watanabe, Atsushi Watanabe, Mikako Yasuoka, Ryota Watanabe, Hironori Oshima, Yuichi Kitagawa, Haruhiko Tokuda, Shumpei Niida, Masayo Kojima

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Akihiko NishikimiBiosafety Division, Research Institute, National Center for Geriatrics and Gerontology, 7-430 Morioka, Obu, Aichi 474-8511, Japan. Electronic address: a-nishikimi@ncgg.go.jp.
Ken WatanabeBioresource Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan; Department of Musculoskeletal Disease, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
Atsushi WatanabeCommunal Laboratory, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
Mikako YasuokaDepartment of Frailty Research, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
Ryota WatanabeDepartment of Frailty Research, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
Hironori OshimaDepartment of Clinical Laboratory, Hospital, National Center for Geriatrics and Gerontology, Aichi, Japan.
Yuichi KitagawaDepartment of Infection Control, Hospital, National Center for Geriatrics and Gerontology, Aichi, Japan.
Haruhiko TokudaBioresource Division, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan; Department of Clinical Laboratory, Hospital, National Center for Geriatrics and Gerontology, Aichi, Japan.
Shumpei NiidaResearch Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
Masayo KojimaDepartment of Frailty Research, Research Institute, National Center for Geriatrics and Gerontology, Aichi, Japan.
National Center for Geriatrics and Gerontology · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Academies and InstitutesAntibodies, ViralFollow-Up StudiesHealth PersonnelHumansJapanPrevalenceSeroepidemiologic StudiesAntibodies, Viral

Identifiers

PMID34728267
PMCPMC8556677
OpenAlexW3210301031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.